• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOFIRE DIAGNOSTICS, LLC BIOFIRE® BLOOD CULTURE IDENTIFICATION 2 (BCID2) PANEL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOFIRE DIAGNOSTICS, LLC BIOFIRE® BLOOD CULTURE IDENTIFICATION 2 (BCID2) PANEL Back to Search Results
Model Number RFIT-ASY-0147
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/15/2024
Event Type  malfunction  
Manufacturer Narrative
Investigation: the patient is a 56 year old female with signs and symptoms of acute encephalopathy.On (b)(6) 2024, a positive blood culture sample was tested on the biofire bcid2 panel.The biofire bcid2 panel reported staphylococcus spp.As detected.On (b)(6) 2024, a positive blood culture sample was repeated on the biofire bcid2 panel.The biofire bcid2 panel reported s.Aureus, and staphylococcus spp.As detected.Gram positive clusters were observed on gram stain and methicillin-sensitive s.Aureus (mssa) was recovered from culture.The customer reported that due to the biofire bcid2 panel result, the patient may have had a delay in treatment.No serious injury or death was reported.Quality control (qc) records for pouch lot# 32kn23 (kit lot# 2635923) were reviewed.This pouch lot passed qc criteria and was found within specifications.The filmarray instrument (serial number# (b)(6) was working within designed specifications.Conclusion: the investigation concluded that the most likely cause for the false negative s.Aureus result on the biofire bcid2 panel was a pouch anomaly.Biofire is continuously monitoring the manufacturing process and has controls in place to ensure the product is manufactured to the highest quality.Each biofire reagent lot is qualified prior to product release; this qualification includes a high statistical-confidence sampling to confirm that the kit components released for customer use are conforming.All qc metrics for the pouch lot and instrument were met, and they passed qc.Review of the associated instrument showed the instrument was performing within specification and was not expected to have contributed to the discrepancies observed by the customer.(b)(4).These rates are within biofire system specifications.According to table 29.Biofire bcid2 panel clinical performance summary, staphylococcus spp.Of the biofire bcid2 panel instructions for use (www.Online-ifu.Com/iti0048), the performance claim for the s.Aureus assay compared to standard manual and automated microbiological/biochemical identification methods showed an overall sensitivity of 100% (95% ci 97.6-100%) and an overall specificity of 99.9% (95% ci 99.5-100%).S.Aureus was detected in both false positive specimens using an additional molecular method.
 
Event Description
Summary: erlanger medical center (chattanooga, tn) reported a potential false negative methicillin-sensitive staphylococcus aureus (mssa) result on the biofire blood culture identification 2 (bcid2) panel after testing a patient blood culture sample.Due to the biofire bcid2 panel result, there may have been a delay in treatment.The investigation concluded that the most likely cause for the false negative s.Aureus result on the biofire bcid2 panel was a pouch anomaly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOFIRE® BLOOD CULTURE IDENTIFICATION 2 (BCID2) PANEL
Type of Device
BIOFIRE® BLOOD CULTURE IDENTIFICATION 2 (BCID2) PANEL
Manufacturer (Section D)
BIOFIRE DIAGNOSTICS, LLC
515 colorow dr
salt lake city UT 84108
Manufacturer (Section G)
BIOFIRE DIAGNOSTICS, LLC
515 colorow dr
salt lake city UT 84108
Manufacturer Contact
515 colorow dr
salt lake city, UT 84108
8017366354
MDR Report Key19147280
MDR Text Key340877688
Report Number3002773840-2024-00307
Device Sequence Number1
Product Code PAM
UDI-Device Identifier00815381020338
UDI-Public00815381020338
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K193519
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 04/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberRFIT-ASY-0147
Device Catalogue NumberRFIT-ASY-0147
Device Lot Number2635923
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received04/19/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured10/26/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age56 YR
Patient SexFemale
-
-